Alicja Chybicka
Overview
Explore the profile of Alicja Chybicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Skalska-Sadowska J, Wachowiak J, Zajac-Spychala O, Niewiadomska-Wojnalowicz I, Januszkiewicz-Lewandowska D, Balwierz W, et al.
Contemp Oncol (Pozn)
. 2014 May;
18(1):48-53.
PMID: 24876821
Aim Of The Study: Recent studies showed relatively better outcome for children with refractory (refAML) and relapsed acute myeloid leukemia (relAML). Treatment of these patients has not been unified within...
22.
Mysliwiec M, Walczak M, Malecka-Tendera E, Dobrzanska A, Cybulska B, Filipiak K, et al.
J Clin Lipidol
. 2014 Mar;
8(2):173-80.
PMID: 24636176
Familial hypercholesterolemia (FH) affects on average 1 in 500 individuals in European countries, and it is estimated that FH in Poland may affect more than 80,000 people. However, in Poland,...
23.
Pietras W, Chaber R, Pela H, Trybucka K, Chybicka A
Adv Clin Exp Med
. 2014 Mar;
23(1):97-102.
PMID: 24596010
Background: Acute lymphoblastic leukemia (ALL) is the most common pediatric neoplasm. Long-term survival is achieved in approximately 80% of patients. One of the more common complications of ALL treatment is...
24.
Mysliwiec M, Walczak M, Malecka-Tendera E, Dobrzanska A, Cybulska B, Filipiak K, et al.
Kardiol Pol
. 2013 Nov;
71(10):1099-105.
PMID: 24197602
No abstract available.
25.
Niedzielska E, Weclawek-Tompol J, Matkowska-Kocjan A, Chybicka A
Adv Clin Exp Med
. 2013 Aug;
22(4):579-84.
PMID: 23986219
Polymorphism in genes coding drug-metabolizing enzymes may cause individual differences in the effectiveness and toxicity of many medications, including cytostatics. Although in recent years intensive treatment has positively influenced the...
26.
Dobrzanska A, Charzewska J, Weker H, Socha P, Mojska H, Ksiazyk J, et al.
Med Wieku Rozwoj
. 2013 Jun;
17(1):94-100.
PMID: 23781564
No abstract available.
27.
Dobrzanska A, Charzewska J, Weker H, Socha P, Mojska H, Ksiazyk J, et al.
Med Wieku Rozwoj
. 2013 Jun;
17(1):90-3.
PMID: 23749701
Updating of the nutritional guidelines for the Polish population requires updates of the nutritional norms for children. We present the Polish Expert Group statement (2012) on intake of selected nutrients...
28.
Balwierz W, Pawinska-Wasikowska K, Klekawka T, Czogala M, Matysiak M, Fic-Sikorska B, et al.
Memo
. 2013 Apr;
6(1):54-62.
PMID: 23565126
Background: Since 1983 four consecutive unified regimens: acute myeloid leukemia-Polish pediatric leukemia/lymphoma study group (AML-PPLLSG) 83, AML-PPLLSG 94, AML-PPLLSG 98 and AML-BFM 2004 Interim, for AML have been conducted by...
29.
Chaber R, Fiszer-Maliszewska L, Noworolska-Sauren D, Kwasnicka J, Wrobel G, Chybicka A
J Pediatr Hematol Oncol
. 2013 Mar;
35(3):180-7.
PMID: 23511489
The BCL-2 protein plays an important role in controlling apoptosis. Disorders of this process can lead to the emergence and development of acute lymphoblastic leukemia (ALL) and can determine the...
30.
Ussowicz M, Jaskowiec A, Meyer C, Marschalek R, Chybicka A, Szczepanski T, et al.
Cancer Genet
. 2012 Jun;
205(5):261-5.
PMID: 22682626
Translocations of the MLL gene are common among neonates and infants with acute lymphoblastic and acute myeloid leukemias. We characterized a new three-way translocation involving MLL in an infant with...